Research1

RESEARCH

TOP

Research1

FEATURED RESEARCH

Regenerative Therapy for Female Reproductive Diseases

Uterine Microenvironment Regulation Mechanism Study

Research1 figure detail

Key Findings

STEM CELL THERAPY

hPVSCs + CYP-A

Human placenta-derived perivascular stem cells & Cyclophilin-A

KEY PATHWAY

HIF1α Pathway

Uterine environment normalization via hypoxia-inducible factor

THERAPEUTIC OUTCOME

Normal Implantation & Delivery

Successful fetal growth and live birth achieved

PATENTS

2 Registered

Patent No. 10-2370535, 10-2477288

Research Areas

  • research areas bx icon1

    Regenerative Therapy for Female Reproductive Diseases

    Stem Cell-Based Uterine Recovery

    Investigating histological and functional recovery of the uterine environment in Asherman's Syndrome (AS) models using stem cells and their derivatives. hPVSCs (human placenta-derived perivascular stem cells) and CYP-A modulate the HIF1α pathway to promote normal implantation and fetal growth.

  • research areas bx icon2

    Uterine Microenvironment Regulation

    Endometrial Cell Interactions

    Analyzing the interactions among epithelial cells, stromal cells, and pro-angiogenic factors in the endometrium to elucidate the mechanisms that establish normal receptivity during the implantation window.

  • research areas bx icon3

    Macrophage Polarity Balance

    Immune Environment Restoration

    Developing strategies to correct M1/M2 macrophage polarity imbalance observed in AS endometrium, restoring a balanced immune environment similar to that of healthy endometrium.

  • research areas bx icon4

    Hypoxia & Fibrosis Inhibition

    Tissue Regeneration Promotion

    Inhibiting hypoxia and fibrosis in AS environments using stem cell-derived factors, while promoting angiogenesis and cell proliferation to induce tissue regeneration.